ArticleCancers2022

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

Silvia Marconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.